Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 2
1998 1
1999 6
2001 4
2002 11
2003 7
2004 14
2005 11
2006 18
2007 16
2008 10
2009 13
2010 14
2011 15
2012 11
2013 7
2014 13
2015 12
2016 12
2017 14
2018 23
2019 31
2020 31
2021 22
2022 14
2023 21
2024 12
2025 9
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

332 results

Results by year

Filters applied: . Clear all
Page 1
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.
Iacovino ML, Arenare L, Morabito A, Tiseo M, Antonuzzo A, Pisconti S, Torre SD, Anselmi E, Rossi M, Giovanardi F, Bollina R, Zanelli F, Galetta D, Leo S, Bilancia D, Biscaldi E, Manzo A, Camisa R, Montanino A, Sforza V, Stefanelli P, Gargiulo P, Piccirillo MC, Maglietta G, Iannelli E, Caminiti C, Maiello E, Pinto C, Perrone F. Iacovino ML, et al. Among authors: galetta d. Lung Cancer. 2026 Apr;214:109312. doi: 10.1016/j.lungcan.2026.109312. Epub 2026 Feb 8. Lung Cancer. 2026. PMID: 41671908 Free article.
Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥ 50%: real-world data from the Italian ATLAS registry.
Passiglia F, Reale ML, Pasello G, Viscardi G, Attili I, Mazzoni F, Galetta D, Catania C, Andrikou K, Russo A, Vavala T, Bulotta A, Calvetti L, Carta AM, Grisanti S, Mariotti S, La Cava G, Dodi A, Scotti V, Del Giudice T, Minuti G, Pizzutillo EG, Chiari R, Della Corte CM, Genova C, Lo Russo G, Pignataro D, Pozzessere D, Roca E, Toschi L, Bennati C, Borra G, Bettini A, Favaretto A, Gelibter A, Gori S, Tabbò F, Pagano M, Pavan A, Belluomini L, Tondulli L, Sergi C, Stanzione B, Malapelle U, Novello S, Bria E. Passiglia F, et al. Among authors: galetta d. Oncologist. 2026 Jan 17;31(2):oyaf428. doi: 10.1093/oncolo/oyaf428. Oncologist. 2026. PMID: 41442468 Free PMC article.
Crizotinib in Patients With ROS1-Positive NSCLC With or Without Brain Metastases: Post Hoc Analysis of Phase II METROS Trial.
Landi L, Chiari R, Tiseo M, Metro G, de Marinis F, Delmonte A, Novello S, Cortinovis DL, Galetta D, Bonanno L, Gridelli C, Morabito A, Grossi F, Torchia A, Giannarelli D, Borra G, Mazzoni F, Pilotto S, Cappuzzo F. Landi L, et al. Among authors: galetta d. JTO Clin Res Rep. 2025 Sep 17;6(12):100909. doi: 10.1016/j.jtocrr.2025.100909. eCollection 2025 Dec. JTO Clin Res Rep. 2025. PMID: 41278398 Free PMC article.
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study.
Gomez-Randulfe I, Monaca F, Cantale O, Reale ML, Mrak L, Zullo L, Diaz SS, Bueno MZ, Maridueña Moreno MA, Davis C, Cox S, Lee D, Shah R, Geldart T, Baena J, Benitez JC, Rosario Garcia Campelo MA, Remon J, Planchard D, Galetta D, Tiseo M, Cortinovis D, Metro G, Bria E, Passiglia F, Novello S, Califano R. Gomez-Randulfe I, et al. Among authors: galetta d. Lung Cancer. 2025 Nov;209:108797. doi: 10.1016/j.lungcan.2025.108797. Epub 2025 Oct 16. Lung Cancer. 2025. PMID: 41135476
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.
Reale ML, Scattolin D, Vitale A, Passiglia F, Grisanti S, Macerelli M, Galetta D, Sini C, Minuti G, Citarella F, Roca E, Agustoni F, Dodi A, Cortinovis D, Belluomini L, Ricciardi S, Veccia A, Pizzutilo EG, Scotti V, Alì G, Mazzoni F, Russo A, Pignataro D, Bulotta A, Piovano P, Sergi C, Bettini A, Genova C, Pavan A, Soto Parra HJ, Ortega C, Pozzessere D, Vavalà T, Chiari R, Zannori C, D'Aveni A, Meoni G, Giannarelli D, Malapelle U, Novello S, Bria E, Pasello G. Reale ML, et al. Among authors: galetta d. Lung Cancer. 2025 Nov;209:108762. doi: 10.1016/j.lungcan.2025.108762. Epub 2025 Sep 24. Lung Cancer. 2025. PMID: 41027387 Free article.
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis.
Monaca F, Gomez-Randulfe I, Walls G, Cantale O, Parreira A, Polidori S, Di Salvatore M, Longo V, Galetta D, Vita E, Martino A, Gambacorta MA, Boldrini L, Summers Y, Tortora G, Blackhall F, Novello S, Chan C, Bria E, Faivre-Finn C, Califano R. Monaca F, et al. Among authors: galetta d. Eur J Cancer. 2025 Jul 25;225:115592. doi: 10.1016/j.ejca.2025.115592. Epub 2025 Jun 25. Eur J Cancer. 2025. PMID: 40580810
332 results